Mold-Tek Packaging Ltd
Mold-Tek Packaging Q3 FY25 earnings call: Revenue & Margins
Q3 FY25 earnings call: what management guided on revenue, margins and order book.
The short version
Overall volume growth for current fiscal year expected close to 8-9%, below earlier guidance of 10-15%. Company expects double-digit volume growth next year, aiming for 10-15%, driven by improved pharma and ABG segment performance. - Pharma segment projected to grow significantly, with revenue potentially reaching INR30-40 crores next year and doubling to INR60-65 crores by FY '27. - EBITDA per kg expected to cross INR38 in Q4 FY25 and potentially INR40 in FY26 due to increased high-margin pharma sales. - Other segments like food, FMCG, and Qpack are also expected to see double-digit growth, offsetting slower growth in paints and lubes. - Margins likely to improve as pharma contribution rises, which offers higher realizations (INR300-350/kg vs.
From Mold-Tek Packaging Ltd's Q3 FY25 earnings-call transcript · updated 23 Aug 2026.
Revenue & Sales Performance
- Overall volume growth for current fiscal year expected close to 8-9%, below earlier guidance of 10-15%. (Page 12)
- Confident of double-digit volume growth next year driven by pharma, paints, and Qpack segments. (Pages 10-11, 14)
- Paint segment volume growth anticipated around 10-15%, with ABG volumes projected to grow 40-50%. (Pages 10, 16)
- Pharma segment targeted to grow from ~INR8 crores this year to INR30-35 crores next year, potentially doubling to INR60-65 crores by FY '27. (Pages 10, 18)
- Thin wall (high-margin) packs expected to register ~15% volume growth next year. (Page 14)
2 more points from Mold-Tek Packaging Ltd's call on revenue
Pro opens every point from 15K+ earnings calls
Profitability & Margins
See what Mold-Tek Packaging Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Pharma segment capex planned for FY '25-'26 is INR 25-40 crores, mainly for additional machines and molds to double capacity; land and building are already in place.
- Potential expansion in Sultanpur premises may require an additional INR 8-10 crores for new buildings.
- Other plants (Cheyyar, Panipat, Mahad) will see mostly balancing equipment investments, with Mahad possibly requiring INR 10-15 crores.
- Total capex for next financial year expected to reduce to around INR 60-65 crores from INR 120-130 crores over the last 3 years.
2 more points from Mold-Tek Packaging Ltd's call on capex
Pro opens every point from 15K+ earnings calls
Top-ranked in Industrial Products
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Mold-Tek Packaging Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
- No specific details on the current or expected order book or pending orders are mentioned explicitly in the transcript.
- However, growth expectations are linked to key customers like Asian Paints and Aditya Birla Group (ABG), with ABG projecting 40-50% volume growth next year, and Mold-Tek being ready with machinery and molds for this.
- The company is optimistic about increasing volumes from pharma, food, FMCG, and thin packs due to new product launches like Surf Excel and Horlicks.
- Asian Paints volumes have declined recently, but the company expects stabilization or recovery, especially with increased adoption of In-Mold Labeling (IML) products.
- Pharma segment is scaling up, with commercial supplies increasing and capacity utilization nearing 40-45%.
2 more points from Mold-Tek Packaging Ltd's call on order book
Pro opens every point from 15K+ earnings calls
Mold-Tek Packaging Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest (Q4 FY26): revenue ₹238 Cr, net profit ₹21 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Mold-Tek Packaging Ltd's management said in earlier quarters
Others in Industrial Products this season
- Welspun Special. (Q3 FY25)
Q3 FY25 Revenue: ₹1,996 million, up 10% YoY from ₹1,819 million in Q3 FY24 (Page 13) . Key concall takeaways from Welspun Specialty Solutions Ltd's Q3 FY25…
- Graphite India (Q3 FY25)
523 Crore, down 24.2% year-on-year (Page 5, 9, 14) . Key concall takeaways from Graphite India Ltd's Q3 FY25 earnings call — and how it ranks against sector…
- PTC Industries Ltd (Q3 FY25)
The provided pages of the investor presentation do not contain any specific revenue, sales, or volume figures for the quarter, nor do they include year-on-year…
- Dhabriya Polywood Ltd (Q3 FY25)
Year-on-Year (YoY) Revenue Growth:** +5.5% No specific volume figures are provided in the presentation. Key concall takeaways from Dhabriya Polywood Ltd's Q3…
Arthneeti Pro · Annual
Mold-Tek Packaging Ltd and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Mold-Tek Packaging Ltd Q3 FY25 results?
Overall volume growth for current fiscal year expected close to 8-9%, below earlier guidance of 10-15%. Company expects double-digit volume growth next year, aiming for 10-15%, driven by improved pharma and ABG segment performance. - Pharma segment projected to grow significantly, with revenue potentially reaching INR30-40 crores next year and doubling to INR60-65 crores by FY '27. - EBITDA per kg expected to cross INR38 in Q4 FY25 and potentially INR40 in FY26 due to increased high-margin pharma sales. - Other segments like food, FMCG, and Qpack are also expected to see double-digit growth, offsetting slower growth in paints and lubes. - Margins likely to improve as pharma contribution rises, which offers higher realizations (INR300-350/kg vs.
What is Mold-Tek Packaging Ltd share price analysis?
Mold-Tek Packaging Ltd currently shows a neutral. The stock trades at a P/E of 30.3 with a market cap of ₹2,307 Cr. Investors should review the full earnings analysis for detailed insights.
Is Mold-Tek Packaging Ltd planning capital expenditure?
Pharma segment capex planned for FY '25-'26 is INR 25-40 crores, mainly for additional machines and molds to double capacity; land and building are already in place.
Keep Mold-Tek Packaging Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.